Real ChatGPT answer · index seed0u5fQ9dLsTEcompleteHealth and wellness · pharmacies and prescriptionsinformational
What are the most common non stimulant alternatives that psychiatrists are currently prescribing to adults who cannot find their Adderall due to the ongoing supply shortage?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What are the most common non stimulant alternatives that psychiatrists are currently prescribing to adults who cannot find their Adderall due to the ongoing supply shortage?
3 real searches · 1 real-search pass
2026 adult ADHD nonstimulant medication treatment atomoxetine viloxazine bupropion guanfacine guideline prescribing shortage AdderallGoogle ↗
OBSERVED
FDA Qelbree viloxazine extended-release adults ADHD approval prescribing information adult trialGoogle ↗
OBSERVED
FDA Strattera atomoxetine adult ADHD prescribing information boxed warningGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
2026 adult ADHD nonstimulant medication treatment atomoxetine viloxazine bupropion guanfacine guideline prescribing shortage Adderall Google ↗
FDA Qelbree viloxazine extended-release adults ADHD approval prescribing information adult trial Google ↗
FDA Strattera atomoxetine adult ADHD prescribing information boxed warning Google ↗
- Treatment ADHD Adults · oregon.gov
- Attention-Deficit/Hyperactivity Disorder in Adults · aafp.org
- Adult ADHD Toolkit For Family Physicians · aafp.org
- DailyMed - QELBREE- viloxazine hydrochloride capsule, extended release · dailymed.nlm.nih.gov
- STRATTERA · accessdata.fda.gov
- Strategies for Substituting ADHD Medications During Stimulant Shortages - Gul Hwang, Hyogun Yi, Aaron Pinkhasov, 2026 · journals.sagepub.com
- ADHD Medication Shortage List 2026: Drug-by-Drug Status · choosingtherapy.com
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2026 adult ADHD nonstimulant medication treatment atomoxetine viloxazine bupropion guanfacine guideline prescribing shortage Adderall OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
FDA Qelbree viloxazine extended-release adults ADHD approval prescribing information adult trial OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
FDA Strattera atomoxetine adult ADHD prescribing information boxed warning OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |